SMTL ID : 6ggn.1

In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x EYH: (4~{S})-4-(4-chloranyl-2-methyl-phenyl)-5-(5-chloranyl-2-methyl-phenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-3-propan-2-yl-4~{H}-pyrrolo[3,4-d]imidazol-6-one(Non-covalent)

EYH.1: 11 residues within 4Å: Chain A: L.39, G.43, I.46, M.47, Y.52, Q.57, F.71, V.78, H.81, I.84, Y.85 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.39, A:L.39, A:I.46, A:V.78, A:I.84 pi-Stacking: A:H.81 Halogen bonds: A:H.81

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 4 residues within 4Å: Chain A: Y.45, K.49, D.65, L.66 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vaupel, A. et al., In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor. Bioorg. Med. Chem. Lett. (2018)

Release Date

2018-09-26

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence